Q4 2017 Holdings
Filed 2018-02-14 | 244 holdings | $4.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Paratek Pharmaceuticals Inc | COM | 699374302 | $350 | 19,580 | 0.0% |
| G1 Therapeutics Inc(GTHXEUR) | COM | 3621LQ109 | $350 | 17,647 | 0.0% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $352 | 20,957 | 0.0% |
| Sangamo Biosciences Inc(SGMO) | COM | 800677106 | $354 | 21,591 | 0.0% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $355 | 36,973 | 0.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $358 | 11,494 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $358 | 16,314 | 0.0% |
| Seres Therapeutics Inc(MCRB1EUR) | COM | 81750R102 | $358 | 35,295 | 0.0% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $358 | 9,552 | 0.0% |
| Juno Therapeutics Inc | COM | 48205A109 | $359 | 7,860 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $360 | 2,187 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $361 | 19,786 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $363 | 21,752 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $366 | 7,893 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $370 | 9,390 | 0.0% |
| Loxo Oncology Inc | COM | 548862101 | $372 | 4,424 | 0.0% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $372 | 11,898 | 0.0% |
| Stemline Therapeutics Inc | COM | 85858C107 | $374 | 23,958 | 0.0% |
| Tetraphase Pharmaceuticals I | COM | 88165N105 | $376 | 59,646 | 0.0% |
| Five Prime Therapeutics Inc(FPRX) | COM | 33830X104 | $381 | 17,371 | 0.0% |
| Idera Pharmaceuticals Inc | COM NEW | 45168K306 | $381 | 180,348 | 0.0% |
| Avexis Inc | COM | 05366U100 | $383 | 3,464 | 0.0% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $383 | 98,726 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $389 | 19,842 | 0.0% |
| Aimmune Therapeutics Inc(AIMT) | COM | 00900T107 | $391 | 10,336 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $391 | 42,485 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $392 | 27,241 | 0.0% |
| Voyager Therapeutics Inc(VYGR) | COM | 92915B106 | $392 | 23,586 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $392 | 25,648 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $394 | 13,917 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $398 | 9,447 | 0.0% |
| Esperion Therapeutics Inc NE(ESPR) | COM | 29664W105 | $399 | 6,057 | 0.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $402 | 4,382 | 0.0% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $405 | 8,541 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $407 | 12,251 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $411 | 32,118 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $414 | 9,748 | 0.0% |
| Ishares TR(INDA) | MSCI INDIA ETF | 46429B598 | $427 | 11,844 | 0.0% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $432 | 57,233 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $456 | 28,196 | 0.0% |
| LA Jolla Pharmaceutical Co(LJPC) | COM PAR $.0001 2 | 503459604 | $463 | 14,394 | 0.0% |
| Ignyta Inc | COM | 451731103 | $612 | 22,936 | 0.0% |
| Vanguard Index FDS(VNQ) | REIT ETF | 922908553 | $702 | 8,461 | 0.0% |
| Intercept Pharmaceuticals in(ICPTUSD) | COM | 45845P108 | $908 | 15,542 | 0.0% |
| Celgene Corp(CELG) | COM | 151020104 | $919 | 8,805 | 0.0% |
| Retrophin Inc | COM | 761299106 | $933 | 44,297 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $936 | 18,610 | 0.0% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $937 | 62,500 | 0.0% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $939 | 95,079 | 0.0% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $949 | 50,726 | 0.0% |